Back to List
Valdecoxib Effectively Treats a Single Moderate
or Severe Acute Migraine Headache
Thomas H.; Le V., Brown M.T.
Posted July 2003
Presented at: 45th Annual Scientific Meeting
American Headache Society
June 19-22, 2003; Chicago, Illinois
Primary: Demonstrate superior analgesic efficacy of single
20- and 40-mg. doses of valdecoxib vs. placebo in treatment of a single moderate or
severe acute migraine headache.
Secondary: Evaluate other efficacy factors, tolerability, and safety of valdecoxib vs. placebo.
A single 20- or 40-mg. dose of valdecoxib is effective and
well tolerated in treatment of a single moderate/severe migraine headache. These
results suggest that valdecoxib 40 mg. is the optimal single dose for treating
single migraine attacks.